Skip to main content

Search complete. 21 mentions across 20 episodes found for "Icehouse Ventures".

Sep 9, 2026

Corin DannCORRESPONDENT
2:42
They got some staff in New Zealand.
Corin DannCORRESPONDENT
2:44
They are backed by Silicon Valley and, uh, New Zealand incubator Icehouse Ventures.
Corin DannCORRESPONDENT
2:49
Harry Melsop says AI robotics companies need ways to test their products before they go into the real world, and Antioch can create high-fidelity systems to do that.
Harry MelsopSOUNDBITE_SPEAKER
3:00
You don't want the first time that you switch a system on to be in the real world where it's operating a, you know, twenty-ton excavator or something like that, right? Like, that's where things become genuinely dangerous.
Josh ComrieHOST
49:09
Get the whale across the line.
Dom SuttonGUEST
49:10
Well, that, that, that, that, that critical point for us was Icehouse Ventures.
Josh ComrieHOST
49:14
Okay.
Dom SuttonGUEST
49:15
So they came on first, and then the rest of the, uh, few angel groups around the country came on, and then a few other people p- piled in privately that, um, sort of had, had a connection with me-
Corin DannCORRESPONDENT
2:42
They've got some staff in New Zealand.
Corin DannCORRESPONDENT
2:44
They are backed by Silicon Valley and New Zealand incubator Icehouse Ventures.
Corin DannCORRESPONDENT
2:49
Harry Melsop says AI robotics companies need ways to test their products before they go into the real world, and Antioch can create high-fidelity systems to do that.
Harry MelsopSOUNDBITE_SPEAKER
3:00
You don't want the first time that you switch a system on to be in the real world where it's operating a 20-ton excavator or something like that, right? That's where things become genuinely dangerous.
Geoffrey HalleyCORRESPONDENT
2:26
Now, it's not its first fundraising, but, uh, the company's called Calocurb, and it's raised twenty-seven million dollars all from local investors.
Geoffrey HalleyCORRESPONDENT
2:34
And those included, uh, Auckland-based Icehouse Ventures, uh, and also KiwiSaver providers Generate and Booster.
Geoffrey HalleyCORRESPONDENT
2:41
So Calocurb actually makes, uh, tablets, uh, and they use a, a patented New Zealand extract that comes from hops grown in Oh- Motueka, and this was discovered by a Crown scientist some time ago.
Geoffrey HalleyCORRESPONDENT
2:55
So the company pays a royalty to the Crown each year for using the IP.
Geoffrey HalleyCORRESPONDENT
2:23
But this time it is biotechnology, if you like.
Geoffrey HalleyCORRESPONDENT
2:26
It's a New Zealand weight management startup which has raised $27 million from local investors, and that includes Auckland-based Icehouse Ventures, as well as KiwiSaver providers Generate and Booster.
Geoffrey HalleyCORRESPONDENT
2:39
Now, CaluCurb is the name of the company, and it makes tablets using a patented New Zealand extract that's grown from hops in Motueka, and it was actually discovered many years ago by Crown scientists.
Geoffrey HalleyCORRESPONDENT
2:51
The company says the extract stimulates the body's own appetite-suppressing hormones, so you perhaps might use it in replacement to things like, say, Wegovi.
Geoffrey HalleyCORRESPONDENT
2:19
Well, we've had a major fundraising success today, and it's from a New Zealand weight management start-up.
Geoffrey HalleyCORRESPONDENT
2:26
Now, it's not its first fundraising, but the company's called Callowcurb, and it's raised $27 million, all from local investors, and those included Auckland-based Icehouse Ventures, And also KiwiSaver providers Generate and Booster.
Geoffrey HalleyCORRESPONDENT
2:41
So Calicube actually makes tablets and they use a patented New Zealand extract that comes from hops grown in Motueka.
Geoffrey HalleyCORRESPONDENT
2:52
And this was discovered by Crown scientists some time ago.
Corin DannCORRESPONDENT
1:40
They have raised $27 million in a capital raise that has just been announced.
Corin DannCORRESPONDENT
1:47
Icehouse Ventures, which is the long-term sort of incubator in New Zealand, been doing a lot of investment for many years now, they have chipped in nearly, I think, $9 million.
Corin DannCORRESPONDENT
1:56
and also one of the big KiwiSaver funds, Generate as well, and some other wholesale investors.
Corin DannCORRESPONDENT
2:03
This company is doing quite well in the US as an alternative to those GLP-1 drugs.
Corin DannCORRESPONDENT
1:40
They have raised $27 million in a capital raise that has just been announced.
Corin DannCORRESPONDENT
1:47
Icehouse Ventures, which is the long-term sort of incubator in New Zealand, been doing a lot of investment for many years now, they have chipped in nearly, I think, $9 million.
Corin DannCORRESPONDENT
1:56
and also one of the big KiwiSaver funds, Generate as well, and some other wholesale investors.
Corin DannCORRESPONDENT
2:03
This company is doing quite well in the US as an alternative to those GLP-1 drugs.
Jamie BeatonGUEST
24:54
We've already gotten some fantastic traction.
Jamie BeatonGUEST
24:56
You know, we've helped companies like Holter, Partly, you know, A16Z, Icehouse Ventures, Blackbird, all these different portfolio companies with their global expansion.
Jamie BeatonGUEST
25:05
Filed a lot of O1 visas for talented Kiwis going global.
Jamie BeatonGUEST
25:09
And we've also expanded into Australia, Canada, and UK visas too.
Sam StubbsGUEST
13:38
I think we're one of the biggest venture capital investors in New Zealand as well.
Sam StubbsGUEST
13:43
We've got, you know, 35 million, I think, with Icehouse Ventures at the moment and some other money we've just committed.
Sam StubbsGUEST
13:52
But I want to go long on that because one of the interesting things about, if you look at our 10-year returns, which are just about to come out, we think they'll be very strong.
Sam StubbsGUEST
14:01
Well, we've been investing heavily in New Zealand.

10 more episodes mention Icehouse Ventures.

Create an account to see the whole feed, search across every transcript, and follow the entities you care about.

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.